ACE BIOSCIENCES ApS
APSDissolvedCVR 25616715Langelinie Allé 35, 2100 København ØForskning og eksperimentel udvikling indenfor bioteknologi· NACE 721100Est. 2000 · 26 years old— employees
Loading company…
Overview
ACE BIOSCIENCES ApS is a Danish APS based in København Ø, operating in the Forskning og eksperimentel udvikling indenfor bioteknologi sector. Incorporated in 2000, the company reported revenue of DKK 14.2m in its latest annual filing.
Revenue 2018
14.2M DKK
−21% vs 2017
EBITDA margin
12.9 %
+47% vs 2017
Net profit 2018
0.7M DKK
+21% vs 2017
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
83.0 %
StrongAmong the 30% highest rated companies in the industry
20142018
Liquidity ratioCurrent assets ÷ Short-term debt
5.9×
StrongAmong the 30% highest rated companies in the industry
20142018
Return on assets (ROA)Net profit ÷ Total assets × 100
3.6 %
AverageAround the average of companies in the same industry
20142018
EBITDA — year on year
DKK millionsKey figures
Annual report 2018| Revenue | 14.2M DKK | -21% |
| EBITDA | 1.8M DKK | +47% |
| Net profit | 0.7M DKK | +21% |
| Total assets | 18.3M DKK | +14% |
| Equity | 15.2M DKK | +15% |
| Employees | — | — |
Company information
Legal name
ACE BIOSCIENCES ApS
CVR number
25616715
Legal form
Anpartsselskab
NACE code
Founded
15 September 2000 · 26 years
Share capital
DKK 500,000
Employees
—
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Address
Langelinie Allé 35, 2100 København Ø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2018), ACE BIOSCIENCES ApS reported revenue of DKK 14.2m, a decrease of 21% on the year before. The figures on this page draw on 5 annual filings covering 2014 to 2018. The bottom line showed a net profit of DKK 658.0k, and the EBITDA margin stood at 12.9%.
At the end of 2018, equity financed 83% of the balance sheet, and current assets covered short-term debt 5.9 times.
Financials
Revenue
DKK millionsEBITDA
DKK millionsIncome statement
DKK thousands| Item | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Revenue | 14,243 | 17,972 | 21,006 | -9,001 | -6,860 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 1,832 | 1,250 | 1,191 | 732 | 32,153 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1,832 | 1,250 | 1,191 | 732 | 32,153 |
| Net financials | -1,066 | -379 | -64 | -369 | -1,487 |
| Profit before tax | 766 | 871 | 1,127 | 363 | 30,666 |
| Tax | 108 | 326 | -7,248 | -51 | 2,190 |
| Net profit | 658 | 545 | 8,375 | 414 | 28,476 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Total assets | 18,284 | 16,054 | 15,664 | 5,959 | 41,558 |
| Equity | 15,179 | 13,160 | 12,205 | 3,830 | 3,416 |
| Long-term debt | 0 | 0 | 3,459 | 0 | 0 |
| Short-term debt | 3,105 | 2,894 | 0 | 2,129 | 38,142 |
| Total debt | 3,105 | 2,894 | 3,459 | 2,129 | 38,142 |
Financial ratios
5-year trendEBITDA margin
12.9 %
20142018
Equity ratio
83.0 %
StrongAmong the 30% highest rated companies in the industry
20142018
Return on equity
4.3 %
AverageAround the average of companies in the same industry
20142018
Net profit margin
4.6 %
AverageAround the average of companies in the same industry
20142018
Asset turnover
0.78×
StrongAmong the 40% highest rated companies in the industry
20142018
Debt / equity
0.20×
StrongAmong the 30% highest rated companies in the industry
20142018
Sector performance
27 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery strong
Among the 10% highest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginStrong
Among the 40% highest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginAverage
Around the average of companies in the same industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Average
Around the average of companies in the same industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Average
Around the average of companies in the same industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Average
Around the average of companies in the same industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Strong
Among the 40% highest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioAverage
Around the average of companies in the same industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioStrong
Among the 30% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioStrong
Among the 30% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery strong
Among the 20% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityAverage
Around the average of companies in the same industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery strong
Among the 10% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery strong
Among the 10% highest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioStrong
Among the 30% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioStrong
Among the 30% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityStrong
Among the 30% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityStrong
Among the 40% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtAverage
Around the average of companies in the same industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtStrong
Among the 30% highest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageAverage
Around the average of companies in the same industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtVery weak
Among the 10% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginWeak
Among the 40% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverStrong
Among the 40% highest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalVery strong
Among the 20% highest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityStrong
Among the 40% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtAverage
Around the average of companies in the same industry
The size of this year's increase or decrease in the company's debt.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|
Former (11)
JM Chief Executive Officer | Chief Executive Officer | 2009 – 2015 |
SS Management | Management | 2000 – 2000 |
HC Management | Management | 2000 – 2004 |
EM Management | Management | 2004 – 2006 |
AK Management | Management | 2000 – 2004 |
CE | Audit | 2000 – 2000 |
NT Management | Management | 2019 – 2019 |
IS Chief Executive Officer | Chief Executive Officer | 2004 – 2009 |
MP Management | Management | 2019 – 2019 |
EJ Management | Management | 2005 – 2005 |
PP Management | Management | 2015 – 2017 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|
Former (26)
BH Board of Directors | Board of Directors | 2006 – 2008 |
JM Chairman | Chairman | 2015 – 2019 |
BF Chairman | Chairman | 2001 – 2003 |
NM Board of Directors | Board of Directors | 2015 – 2016 |
PT Board of Directors | Board of Directors | 2009 – 2013 |
SL Chairman | Chairman | 2009 – 2009 |
LS Chairman | Chairman | 2003 – 2009 |
MP Chairman | Chairman | 2014 – 2015 |
DC Board of Directors | Board of Directors | 2001 – 2009 |
PP Board of Directors | Board of Directors | 2013 – 2014 |
RS Board of Directors | Board of Directors | 2001 – 2005 |
SV Board of Directors | Board of Directors | 2009 – 2013 |
SH Board of Directors | Board of Directors | 2001 – 2006 |
BJ Board of Directors | Board of Directors | 2009 – 2013 |
CM Board of Directors | Board of Directors | 2015 – 2019 |
DP Board of Directors | Board of Directors | 2014 – 2015 |
NT Board of Directors | Board of Directors | 2019 – 2019 |
DJ Board of Directors | Board of Directors | 2007 – 2009 |
MP Chairman | Chairman | 2019 – 2019 |
TT Chairman | Chairman | 2009 – 2010 |
EJ Board of Directors | Board of Directors | 2001 – 2007 |
AP Chairman | Chairman | 2013 – 2014 |
CA Board of Directors | Board of Directors | 2009 – 2009 |
DC Board of Directors | Board of Directors | 2008 – 2009 |
PP Board of Directors | Board of Directors | 2015 – 2017 |
GT Board of Directors | Board of Directors | 2008 – 2009 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
ZYMENEX HOLDING ApS
ACE BIOSCIENCES ApS Board network connections
Board members of ACE BIOSCIENCES ApS also hold positions in 95 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sten Verland | Board of Directors | 19 companiesMany roles |
| Søren Lemonius | Chairman | 18 companiesMany roles |
| Steen Schierbeck | Management | 10 companiesMany roles |
| Per Toft Valstorp | Board of Directors | 9 companiesMany roles |
| Erik Johannes Møller | Management | 8 companiesMany roles |
| Ejvind Mørtz | Management | 6 companiesMany roles |
| Bo Jesper Hansen | Board of Directors | 6 companiesMany roles |
| Gudmund Tyge Korsgaard | Board of Directors | 5 companies |
| Charlotte Antonsen Dalgas | Board of Directors | 4 companies |
| Thomas Tscherning | Chairman | 3 companies |
| Jens Morten Fogh | Chief Executive Officer | 2 companies |
| Ingelise Saunders | Chief Executive Officer | 2 companies |
| Angus King | Management | 1 company |
| Carl Edvard Gudbergsen | Audit | 1 company |
| Birgitte Holck-Andersen | Board of Directors | 1 company |
Frequently asked questions
What is the CVR number of ACE BIOSCIENCES ApS?
ACE BIOSCIENCES ApS is registered with CVR / Virk under CVR 25616715.
What is the revenue of ACE BIOSCIENCES ApS?
ACE BIOSCIENCES ApS reported revenue of DKK 14.2m in 2018.
Where is ACE BIOSCIENCES ApS headquartered?
ACE BIOSCIENCES ApS's registered address is Langelinie Allé 35.